Compare First-Line Meds for Parkinson’s
May 2022
About 60,000 people in the US are diagnosed with Parkinson’s disease each year...and you’ll need to help sort through first-line meds.
Meds don’t slow progression, so consider using a “wait-and-see” approach...starting when symptoms impair function or quality of life.
Tailor med choice based on age, symptom severity, etc.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote